 | |
| Danone Analysts' Consensus | |
| April 4th 2013 | | | Q1 2013, Q2 2013, H1 2013 & FY 2013 | | |
| | | |
| | | | |
| | | | | | Consensus | | Consensus | | Consensus | |
| | | | | | Q1 2013 | | | | Q2 2013 | | | | FY 2013 | | |
| | | | | Median | Low | High | | Median | Low | High | | Median | Low | High | |
| Sales | | | | | | | | | | | | | | |
| | Fresh Dairy | € mln | | 3,042 | 2,912 | 3,135 | | 3,096 | 2,903 | 3,317 | | 12,305 | 11,673 | 12,562 | |
| | volume growth | % | | 0.5% | (1.8)% | 3.6% | | 1.2% | (1.2)% | 5.4% | | 1.5% | (0.2)% | 5.0% | |
| | value growth | % | | 0.7% | (2.0)% | 2.5% | | 0.9% | (3.1)% | 2.3% | | 0.8% | (2.1)% | 2.5% | |
| | organic growth | % | | 1.0% | (1.5)% | 2.3% | | 2.0% | 0.0% | 3.9% | | 2.4% | 1.0% | 3.5% | |
| | | | | | | | | | | | | | | | | |
| | Waters | € mln | | 890 | 853 | 958 | | 1,098 | 1,061 | 1,173 | | 3,903 | 3,751 | 4,030 | |
| | volume growth | % | | 5.0% | 1.0% | 10.0% | | 6.0% | 1.0% | 12.0% | | 6.0% | 1.0% | 8.2% | |
| | value growth | % | | 2.0% | (1.3)% | 6.0% | | 4.0% | 0.1% | 6.3% | | 3.2% | 0.8% | 8.1% | |
| | organic growth | % | | 7.0% | 3.8% | 11.0% | | 10.0% | 7.0% | 15.2% | | 8.6% | 7.0% | 10.9% | |
| | | | | | | | | | | | | | | | |
| | Baby Nutrition | € mln | | 1,113 | 1,055 | 1,159 | | 1,160 | 1,107 | 1,210 | | 4,628 | 4,444 | 4,810 | |
| | volume growth | % | | 6.0% | 3.0% | 9.0% | | 5.0% | 1.1% | 8.0% | | 6.0% | 2.0% | 9.0% | |
| | value growth | % | | 4.5% | 1.5% | 6.5% | | 4.0% | 1.5% | 6.0% | | 4.0% | 1.5% | 6.3% | |
| | organic growth | % | | 11.0% | 7.0% | 14.0% | | 9.5% | 5.4% | 12.0% | | 10.1% | 6.0% | 11.6% | |
| | | | | | | | | | | | | | | | | |
| | Medical Nutrition | € mln | | 316 | 301 | 325 | | 338 | 330 | 346 | | 1,350 | 1,330 | 1,373 | |
| | volume growth | % | | 6.0% | 4.0% | 9.0% | | 6.0% | 5.0% | 8.6% | | 6.3% | 5.0% | 7.8% | |
| | value growth | % | | (1.0)% | (2.1)% | 1.0% | | (1.0)% | (2.1)% | 1.0% | | (0.5)% | (1.6)% | 1.0% | |
| | organic growth | % | | 5.2% | 3.0% | 7.0% | | 5.5% | 4.0% | 7.5% | | 5.8% | 4.9% | 7.2% | |
| | | | | | | | | | | | | | | | |
| Total Sales Danone | € mln | | 5,358 | 5,203 | 5,513 | | 5,709 | 5,512 | 5,883 | | 22,218 | 1,337 | 22,449 | |
| organic growth | volume growth | % | | 2.6% | 1.5% | 4.1% | | 3.0% | 1.9% | 5.3% | | 3.3% | 2.4% | 5.0% | |
| | value growth | % | | 1.6% | 0.3% | 2.4% | | 2.0% | 0.1% | 3.0% | | 1.8% | 0.4% | 2.7% | |
| | Organic growth | % | | 4.2% | 2.3% | 5.2% | | 5.4% | 3.7% | 6.4% | | 5.3% | 4.5% | 6.2% | |
| | scope growth | % | | 2.5% | (1.0)% | 3.6% | | 3.0% | 0.0% | 6.5% | | 2.9% | 0.0% | 3.3% | |
| | forex growth | % | | (2.0)% | (2.7)% | 0.4% | | (1.9)% | (3.5)% | 0.0% | | (2.0)% | (3.5)% | 0.0% | |
| | Reported growth | % | | 4.6% | 1.4% | 7.7% | | 6.2% | 2.9% | 9.8% | | 6.4% | 2.7% | 7.6% | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | Consensus | | Consensus | |
| | | | | | | | | | | H1 2013 | | | | FY 2013 | | |
| | | | | | | | | | Median | Low | High | | Median | Low | High | |
| | | | | | | | | | | | | | | | | |
| Trading Operating Profit (EBIT) | | | | | | | | | | | | | | |
| | Fresh Dairy | € mln | | | | | | 630 | 566 | 670 | | 1,386 | 1,299 | 1,454 | |
| | Waters | € mln | | | | | | 272 | 260 | 283 | | 520 | 445 | 534 | |
| | Baby Nutrition | € mln | | | | | | 455 | 426 | 469 | | 909 | 871 | 932 | |
| | Medical Nutrition | € mln | | | | | | 119 | 110 | 124 | | 240 | 218 | 264 | |
| Total EBIT Danone | € mln | | | | | | 1,474 | 1,398 | 1,520 | | 3,057 | 2,965 | 3,106 | |
| | | | | | | | | | | | | | | | |
| Total EBIT Margin Danone | % | | | | | | 13.3% | 12.9% | 13.6% | | 13.8% | 13.7% | 14.0% | |
| | | | | | | | | | | | | | | | |
| Other operating items | € mln | | | | | | 0 | (250) | 0 | | 0 | (500) | 0 | |
| | | | | | | | | | | | | | | | |
| Operating income | € mln | | | | | | 1,470 | 1,247 | 1,520 | | 3,047 | 2,508 | 3,092 | |
| | | | | | | | | | | | | | | | |
| Cost of net debt | € mln | | | | | | (85) | (140) | (68) | | (180) | (285) | (149) | |
| Other financial income/(expense) | € mln | | | | | | (60) | (68) | (42) | | (120) | (132) | (84) | |
| Total financial cost | € mln | | | | | | (142) | (164) | (120) | | (296) | (351) | (243) | |
| | | | | | | | | | | | | | | | |
| Income before tax | € mln | | | | | | 1,327 | 1,103 | 1,400 | | 2,751 | 2,217 | 2,814 | |
| | | | | | | | | | | | | | | | |
| Income tax | € mln | | | | | | (376) | (409) | (313) | | (788) | (841) | (680) | |
| | | | | | | | | | | | | | | | |
| Net income/(loss) of affiliates | € mln | | | | | | 28 | 15 | 43 | | 50 | 30 | 88 | |
| | | | | | | | | | | | | | | | |
| Net income | € mln | | | | | | 972 | 797 | 1,042 | | 1,968 | 1,540 | 2,167 | |
| - Group share | € mln | | | | | | 896 | 712 | 998 | | 1,844 | 1,265 | 2,059 | |
| - Non controlling interest share | € mln | | | | | | 74 | 33 | 99 | | 145 | 65 | 181 | |
| | | | | | | | | | | | | | | | |
| Basic EPS | | | | | | | 1.50 | 1.12 | 1.67 | | 3.12 | 2.37 | 3.47 | |
| Average no. of shares to calculate basic EPS | | | | | | 595 | 586 | 604 | | 594 | 586 | 604 | |
| | | | | | | | | | | | | | | | |
| Diluted EPS | | | | | | | 1.49 | 1.12 | 1.66 | | 3.10 | 2.37 | 3.45 | |
| Average no. of shares to calculate diluted EPS | | | | | | 598 | 587 | 604 | | 595 | 587 | 604 | |
| | | | | | | | | | | | | | | | |
| Cash Flow from operating activities | € mln | | | | | | 1,167 | 1,025 | 1,337 | | 2,390 | 2,213 | 2,858 | |
| Net change in working capital | € mln | | | | | | 58 | 13 | 180 | | 97 | (173) | 493 | |
| Capital expenditure | € mln | | | | | | (500) | (525) | (498) | | (1,008) | (1,125) | (828) | |
| Disposal of tangible assets | € mln | | | | | | 0 | 0 | 70 | | 0 | 0 | 180 | |
| Transaction fees | € mln | | | | | | 0 | 0 | 0 | | 0 | 0 | 470 | |
| Free Cash Flow* | € mln | | | | | | 750 | 680 | 897 | | 1,550 | 1,213 | 2,096 | |
| | | | | | | | | | |
| - All figures exclude exceptional items | | |
| - Consensus is based on inputs from 26 analysts | | | |
| - Danone does not endorse these consensus numbers | | |
| | |
| * Cash flow from operations less capital expenditure (net of disposals) and excluding business combinations fees | |